Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 19 | $9,442,212 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
28 Nov 2022 19:30 | DNLI | Denali Therapeutics Inc | TESSIER-LAVIGNE MARC | Director | 23 Nov 2022 | Sale | 20,000 | 30.48 | 609,600 | D |
03 Nov 2022 17:37 | DNLI | Denali Therapeutics Inc | TESSIER-LAVIGNE MARC | Director | 02 Nov 2022 | Sale | 11,252 | 30.33 | 341,273 | D |
03 Nov 2022 17:37 | DNLI | Denali Therapeutics Inc | TESSIER-LAVIGNE MARC | Director | 01 Nov 2022 | Sale | 8,748 | 30.2 | 264,190 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 03 Oct 2022 | Sale | 3,612 | 718 | 2,593,416 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 30 Sep 2022 | Sale | 3,428 | 698 | 2,392,744 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 20 | 704.83 | 14,097 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 16 | 702.36 | 11,238 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 80 | 699.82 | 55,986 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 208 | 698.44 | 145,276 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 160 | 697.29 | 111,566 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 85 | 696.13 | 59,171 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 554 | 691.59 | 383,141 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 692 | 690.65 | 477,930 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 1,009 | 689.56 | 695,766 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 637 | 688.71 | 438,708 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 321 | 687.9 | 220,816 | D |
03 Oct 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | TESSIER-LAVIGNE MARC | Director | 29 Sep 2022 | Sale | 16 | 686.89 | 10,990 | D |
30 Sep 2022 16:50 | DNLI | Denali Therapeutics Inc | TESSIER-LAVIGNE MARC | Director | 28 Sep 2022 | Sale | 4,423 | 31.08 | 137,467 | D |
30 Sep 2022 16:50 | DNLI | Denali Therapeutics Inc | TESSIER-LAVIGNE MARC | Director | 28 Sep 2022 | Sale | 15,577 | 30.74 | 478,837 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)